Back to search

Article

De novo design of anti-variant COVID-19 Vaccine

2023-06-20

Abstract excerpt

Recent studies have demonstrated the effectiveness of hybrid SARS-CoV-2 vaccines that combine the wild-type nucleocapsid (N) and Spike (S) proteins. Based on this strategy, we have further enhanced the idea by incorporating the spike protein with mutations from delta and post-delta omicron variants of concern (VOC). Both delta and omicron mark the transition of vaccine driven viral immunity and resistance, so thei...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
1b9fff20-4047-554e-81f8-56d4a3ee5f40
DOI
10.22541/au.168726822.26143817/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
De novo design of anti-variant COVID-19 VaccineDOI 10.22541/au.168726822.26143817/v1
Select a neighboring publication to make it the new centre.